Press Release: Aptus and Array BioPharma announce drug discovery collaboration; small molecule drug discovery agreement targets GPCRs.

Aptus Genomics Inc (Aptus) and Array BioPharma Inc announced a drug discovery collaboration agreement to create small molecule therapeutics against select G-Protein Coupled Receptor (GPCR) targets. Under the terms of the agreement, Aptus will use its proprietary AptuScreen technology to screen Array BioPharma's Lead Generation Libraries, on a non- exclusive basis. Array BioPharma will work exclusively with Aptus on a select number of GPCR targets and will provide Aptus access to its Lead Generation Libraries in exchange for common stock in Aptus. Array BioPharma will use the Array Discovery Platform to optimize leads resulting from the collaboration, and will receive research …